Results 271 to 280 of about 53,329 (292)

EVIDENCE FOR CONTAMINATION OF HERBAL ERECTILE DYSFUNCTION PRODUCTS WITH PHOSPHODIESTERASE TYPE 5 INHIBITORS

Journal of Urology, 2005
Neil Fleshner, Hans Adomat, Andy Eberding   +2 more
exaly  

Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells

Biochemical Pharmacology, 1994
Joseph J Krzanowski, James B Polson, X Pan   +2 more
exaly  

Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis

European Urology Focus, 2017
Marrissa Martyn-St James, Katy Cooper, Shijie Ren   +2 more
exaly  

CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-a]thiadiazine 2,2-dioxides: clues for the design of phosphodiesterase 7 inhibitors

European Journal of Medicinal Chemistry, 2001
Ana Castro, Carmen Gil, VÍCTOR Segarra   +2 more
exaly  

Phosphodiesterase Inhibitors

2007
openaire   +2 more sources

Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors

Expert Opinion on Drug Metabolism and Toxicology, 2017
Isaac Yi Kim
exaly  

Phosphodiesterase Inhibitors

2012
openaire   +1 more source

Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential

Bioorganic and Medicinal Chemistry, 2016
Nariman F Salakhutdinov, Olga I Lavrik
exaly  

The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice

Journal of Psychopharmacology, 2012
Shervin Liddie, Karen L Anderson, Yossef Itzhak   +2 more
exaly  

The Relationship between Erectile Dysfunction and Lower Urinary Tract Symptoms and the Role of Phosphodiesterase Type 5 Inhibitors

European Urology, 2009
Tobias S Kohler
exaly